Abstract CN71
Background
Approximately 50% of women receiving chemotherapy for breast cancer develop chemotherapy induced peripheral neuropathy (CIPN) and is associated with significant disability and poor recovery. Common symptoms of CIPN include pain, altered sensation, reduced or absent reflexes, muscle weakness, reduced balance control and insecure gait. These symptoms affect activities of daily living and reducing patients' quality of life. CIPN also cause treatment delays, dose reductions, or even discontinuation of therapy, which can affect the outcome and compromise survival. To date, CIPN cannot be prevented and effective treatment options are lacking. Preliminary data indicate that whole body vibration (WBV) exercise may have a preventive effect on the onset of CIPN. However, how WBV compares to conventional cardio and resistance exercise (CAR) exercise for alleviate CIPN has not yet been studied. The aim is to compare the effects of WBV exercise compared to CAR on the primary outcome of CIPN symptoms and secondary outcomes of balance, physical function, and quality of life.
Methods
This prospective, multicenter, two-armed, randomized pilot study will include 44 women, assigned randomly either to the WBV group or the CAR group. Patients will exercise twice per week (at Karolinska) for 12 weeks. Measurements are performed at baseline, 3 and 6 months. Inclusion criteria: breast cancer diagnosis, aged 18–65 years, ECOG performance status of 0–2, completed chemotherapy in the past 6 month and remaining CIPN symptoms. Exclusion criteria: pre-existing neuropathy of other cause, severe cardiovascular disease, regular intake of analgesics, smoking. Measurement: CIP-NAT, CIPN-R-ODS, QLQ-C30, PainDETECT, Monofilament, Turn fork test, Tendon reflexes, Balance and Muscle strength tests.
Results
Based on previous study findings, we hypothesize that WBV exercise compared to CAR will reduce symptoms to a larger degree, such as the loss of peripheral deep sensitivity, pain, weakened or absent reflexes and loss of balance control.
Conclusions
Hopefully patients will experience an improvement in physical function and quality of life.
Clinical trial identification
NCT05361018.
Editorial acknowledgement
Legal entity responsible for the study
Y. Wengström.
Funding
Swedish Breast Cancer Association.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN48 - Mobile response and prevention unit: Mobile information and management unit a collaboration between “Care In Adult Cancer Patients” nursing research laboratory and “Cancer Guidance Center” a non-profit organization (Kapa3)
Presenter: Evangeli Bista
Session: Poster session 25
Resources:
Abstract
CN49 - Nurse–patient sexual health communication in gynecological cancer follow-up: A qualitative study from nurses’ perspectives
Presenter: Anita Paulsen
Session: Poster session 25
Resources:
Abstract
CN50 - Patient-reported outcome measures and supportive care need assessment in patients in a slovenian tertiary oncology centre
Presenter: Majda Causevic
Session: Poster session 25
Resources:
Abstract
CN51 - Psychometric properties of the Turkish version of the nurse spiritual therapeutic scale for oncology patients and caregivers
Presenter: Remziye Semerci
Session: Poster session 25
Resources:
Abstract
CN52 - Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects
Presenter: Ariadna Garcia Rodriguez
Session: Poster session 25
Resources:
Abstract
CN53 - Sexual function in survivors of hematological malignancy and autologous hematopoietic stem cell transplantation
Presenter: Ioanna Tsatsou
Session: Poster session 25
Resources:
Abstract
CN54 - Sexual health in women with breast cancer undergoing hormonal treatment
Presenter: Cristina Tebar
Session: Poster session 25
Resources:
Abstract
CN55 - The impact of psychosocial support on the overall health of cancer patients in the COVID-19 era
Presenter: Gianluca Catania
Session: Poster session 25
Resources:
Abstract
CN56 - Well-being and healthcare concerns of patients with advanced renal cell carcinoma: The RCC PROMs international survey
Presenter: Grigorios Kotronoulas
Session: Poster session 25
Resources:
Abstract
CN57 - Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT)
Presenter: Canova Canova
Session: Poster session 25
Resources:
Abstract